| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,305 |
4,432 |
$134K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,633 |
1,395 |
$59K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
450 |
401 |
$27K |
| 11721 |
|
521 |
448 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,289 |
970 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
170 |
153 |
$7K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
571 |
413 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
239 |
179 |
$4K |
| 20605 |
|
117 |
91 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
46 |
38 |
$2K |
| 20600 |
|
55 |
41 |
$1K |
| 11055 |
|
42 |
38 |
$800.54 |
| 20550 |
|
22 |
12 |
$659.17 |
| 11720 |
|
47 |
39 |
$615.69 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
22 |
18 |
$107.92 |